Drug recall · August 28, 2013
Nystatin Oral Suspension recall
Why: Failed Impurites/Degradation Specifications: Test failure of single largest peak at 18 months.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Nystatin Oral Suspension, USP 500,000 units/ 5 mL (NDC 66689-037-01 ) Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771
- Lots / codes
Lot # 240200, 243000, 244800, 245600, 250800 and 253600. Exp 06/13.
- Quantity
- 1,707,050 cups / 5ml ea.
- Company
- VistaPharm, Inc., Largo, FL
- Distribution
- Nationwide.
- Initiated
- July 4, 2013 · Voluntary: Firm initiated
- Classified
- August 21, 2013
- Reported
- August 28, 2013
- Ended
- August 4, 2014
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nystatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.